The findings provide further support of recommendations in the clinical guidelines to favor one therapy over the other. Patients with chronic obstructive pulmonary disease (COPD) being treated with ...

When Kris Mayotte recruited Noah Laba to Colorado College, he wasn’t chasing a flash of potential — he was building a foundation. The newly hired head coach had a vision: rebuild the Tigers into a ...

_ A phase II multi-dose study shows fast-acting and long-lasting efficacy of LAS100977, Almirall_s novel once-daily inhaled beta2 agonist (LABA), for the treatment of bronchoconstriction in asthmatic ...

Long-acting B-agonist (LABA) monotherapy among patients with asthma is rare. Of those with continued LABA monotherapy, most had missed opportunities for therapy change or education. Administrative ...

Please provide your email address to receive an email when new articles are posted on . Inhalers with a long-acting muscarinic antagonist and a long-acting beta agonist (LABA) resulted in “better ...

Patients with chronic obstructive pulmonary disease (COPD) experienced significantly fewer acute exacerbations when a long-acting muscarinic antagonist (LAMA) was added to a long-acting beta agonist ...

Please provide your email address to receive an email when new articles are posted on . Moving from a low-dose inhaled corticosteroid to a medium-dose inhaled corticosteroid plus a long-acting beta ...